Ranibizumab proves instrumental for DME patients in RIDE, RISE trials
September 15th 2015Ranibizumab provided improvements in visual acuity and DR that were stable over the long term when the drug was administered on an as-needed regimen to patients with diabetic macular edema in the RIDE and RISE trials.
How would an ophthalmologist respond when faced with death?
September 15th 2015How does any of this relate to ophthalmology? In our offices, we don’t face dramatic this-or-that moments of choice that define us in the way these young men were defined by their decision. For ophthalmologists there is always only one option-to do whatever is in the best interest of our patients.
Staged cataract surgery: Art of optimization to individual outcomes
September 15th 2015In this second part of a four-part column, Arun C. Gulani, MD, places the spotlight on staged cataract surgery. The first part of the series discussed the concept and approach to designing primary cataract surgery.
Artificial cornea may be alternative to repeat PK in certain patients
September 1st 2015Findings of a retrospective case review show that eyes that underwent implantation of the Boston Type 1 keratoprosthesis had greater improvement in visual acuity than those undergoing repeat donor corneal transplantation.
En-bloc PK with KLAL a novel approach for severe limbal stem cell deficiency
September 1st 2015Simultaneous en-bloc central penetrating keratoplasty and peripheral lamellar keratoplasty with annular keratolimbal allograft transplantation provides patients with severe limbal stem cell deficiency the benefit of rapid visual recovery.